Terms: = Endocrine gland cancer AND ENO2, HEL-S-279, NSE AND Treatment
49 results:
1. [Clinical features of patients with metastatic pheochromocytoma/paraganglioma].
Cui YY; Zhou Y; Gao YJ; Li TY; Wang Y; Zhang WQ; Zhou T; Chen S; Tong AL
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(14):1174-1179. PubMed ID: 38583049
[No Abstract] [Full Text] [Related]
2. Exploring the application value of pro-gastrin-releasing peptide in the clinical diagnosis and surgical treatment of medullary thyroid carcinoma.
Miao Q; Lv X; Luo L; Zhang J; Cai B
Cancer Med; 2023 Oct; 12(19):19576-19582. PubMed ID: 37754747
[TBL] [Abstract] [Full Text] [Related]
3. High-Fat Mouse Model to Explore the Relationship between Abnormal Lipid Metabolism and Enolase in Pancreatic cancer.
Qin L; Sun K; Shi L; Xu Y; Zhang R
Mediators Inflamm; 2023; 2023():4965223. PubMed ID: 37731842
[TBL] [Abstract] [Full Text] [Related]
4. EMT Molecular Signatures of Pancreatic Neuroendocrine Neoplasms.
Venugopal A; Michalczyk A; Khasraw M; Ackland ML
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362433
[TBL] [Abstract] [Full Text] [Related]
5. Advantages and clinical significance of enhanced CT combined with BRAF V600E gene detection in the diagnosis of papillary thyroid carcinoma.
Zhang J; Zhang J; Han J
Med Eng Phys; 2022 Dec; 110():103862. PubMed ID: 35933302
[TBL] [Abstract] [Full Text] [Related]
6. [Comparison of clinical features between sporadic pancreatic neuroendocrine tumors and those associated with multiple endocrine neoplasia type 1].
Gu DY; Fu Q; Xue BY; Kan JB; Bai JA; Tang QY
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):1014-1019. PubMed ID: 35399021
[No Abstract] [Full Text] [Related]
7. Serum Biomarker Status with a Distinctive Pattern in Prognosis of Gastroenteropancreatic Neuroendocrine Carcinoma.
Zhang J; Cao Y; Zhang P; Zhang X; Li J; Zhou J; Wang X; Peng Z; Sun Y; Li J; Shen L; Lu M
Neuroendocrinology; 2022; 112(8):733-743. PubMed ID: 34592743
[TBL] [Abstract] [Full Text] [Related]
8. A case report of rare ectopic pheochromocytoma adjacent to pancreas.
Jiang C; Zhao J; Sun L; Cai B
Medicine (Baltimore); 2020 Jun; 99(25):e20858. PubMed ID: 32569235
[TBL] [Abstract] [Full Text] [Related]
9. The Feasibility of Serum Multiple Tumor Markers Test Between Patients with Primary Pancreatic cancer and Those with Benign Pancreatic Cystic Disease.
Lee JH
Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625360
[TBL] [Abstract] [Full Text] [Related]
10. Identification of Potential Biomarkers with Diagnostic Value in Pituitary Adenomas Using Prediction Analysis for Microarrays Method.
Peng H; Deng Y; Wang L; Cheng Y; Xu Y; Liao J; Wu H
J Mol Neurosci; 2019 Nov; 69(3):399-410. PubMed ID: 31280474
[TBL] [Abstract] [Full Text] [Related]
11. [Comprehensive treatment of adrenal cortical carcinoma].
Deng JH; Li HZ; Ji ZG; Zhang YS; Liu GH
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 51(2):298-301. PubMed ID: 30996372
[TBL] [Abstract] [Full Text] [Related]
12. First reported case of a collision tumor composed of pancreatic adenocarcinoma and retroperitoneal liposarcoma: a case report.
Buchner D; Hieggelke L; Löser H; Bruns CJ; Quaas A; Ghadimi MPH
BMC Cancer; 2018 Dec; 18(1):1243. PubMed ID: 30541485
[TBL] [Abstract] [Full Text] [Related]
13. An Interesting Case of Hepatic Adrenocortical Carcinoma.
Permana H; Darmawan G; Ritonga E; Kusumawati M; Miftahurachman M; Soetedjo NN
Acta Med Indones; 2018 Jul; 50(3):257-259. PubMed ID: 30333277
[TBL] [Abstract] [Full Text] [Related]
14. Neuroendocrine Breast Carcinomas Share Prognostic Factors with Gastroenteropancreatic Neuroendocrine Tumors: A Putative Prognostic Role of Menin, p27, and SSTR-2A.
Roininen N; Takala S; Haapasaari KM; Jukkola-Vuorinen A; Mattson J; Heikkilä P; Karihtala P
Oncology; 2019; 96(3):147-155. PubMed ID: 30282082
[TBL] [Abstract] [Full Text] [Related]
15. endocrine mucin-producing sweat gland carcinoma of the eyelid: A clinical and histological conundrum.
Nair AG; Bhargava R; Furniturewala AU
Indian J Ophthalmol; 2018 Jul; 66(7):1042-1044. PubMed ID: 29941769
[TBL] [Abstract] [Full Text] [Related]
16. [A Case of Adrenal Leiomyosarcoma].
Taniguchi A; Ujike T; Fujita K; Uemura M; Kiuchi H; Imamura R; Miyagawa Y; Nonomura N; Morii E
Hinyokika Kiyo; 2017 Nov; 63(11):465-469. PubMed ID: 29232797
[TBL] [Abstract] [Full Text] [Related]
17. Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort.
Walter T; Tougeron D; Baudin E; Le Malicot K; Lecomte T; Malka D; Hentic O; Manfredi S; Bonnet I; Guimbaud R; Coriat R; Lepère C; Desauw C; Thirot-Bidault A; Dahan L; Roquin G; Aparicio T; Legoux JL; Lombard-Bohas C; Scoazec JY; Lepage C; Cadiot G;
Eur J Cancer; 2017 Jul; 79():158-165. PubMed ID: 28501762
[TBL] [Abstract] [Full Text] [Related]
18. [Advances of circulating biomarkers in gastroenteropancreatic neuroendocrine neoplasms].
Chen L; Chen M; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):357-360. PubMed ID: 28338171
[TBL] [Abstract] [Full Text] [Related]
19. Clinical applicability of multi-tumor marker protein chips for diagnosing ovarian cancer.
Bian J; Li B; Kou XJ; Wang XN; Sun XX; Ming L
Asian Pac J Cancer Prev; 2014; 15(19):8409-11. PubMed ID: 25339038
[TBL] [Abstract] [Full Text] [Related]
20. [Primary neuroendocrine tumor of the testis: clinicopathological study of 7 cases].
Liu FF; Zheng JF; Zhou LT; Wang CC; Wang JJ; Shen Q; Yu B; Ma HH; Wang JD; Shi QL
Zhonghua Nan Ke Xue; 2014 Jan; 20(1):63-7. PubMed ID: 24527540
[TBL] [Abstract] [Full Text] [Related]
[Next]